# Infinity Pharmaceuticals, Inc. (INFIQ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/INFIQ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 1.42M | $ -22.71M | $ -22.26M | N/A | $ -37.41M |
| 2022 | $ 1.40M | $ -22.28M | $ -20.44M | $ 48.13M | $ -19.05M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -1.57 |
| Current Ratio | 1.65 |

## Other views

- [Metrics](https://sponda.capital/en/INFIQ.md)
- [Charts](https://sponda.capital/en/INFIQ/charts.md)
- [Compare](https://sponda.capital/en/INFIQ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.